• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    J

    John F. Kennedy Medical Center

    EST. 1967
    205论文总数
    1.1万引用总数

    John F. Kennedy Medical Center (JFKMC), an affiliate of Hackensack Meridian Health (HMH), is a 499-bed full-service, acute care hospital, and the home of the JFK Johnson Rehabilitative Institute. It's affiliated with Hackensack Meridian School of Medicine at Seton Hall University and Robert Wood Johnson Medical School, and is located in Edison, New Jersey. In 2021 it announced an affiliation with the St. Joseph’s Wayne Medical Center, also in New Jersey.

    论文量&引用量时间轴

    机构学者

    排序
    Jawad F. Kirmani
    Jawad F. Kirmani
    Hackensack Meridian Health JFK Medical Center;Jersey Shore University Medical Center
    论文:29引用:0H-index:0
    Moussavi Mohammad
    Moussavi Mohammad
    JFK Med Cntr, Inst Neurosci
    论文:17引用:0H-index:0
    Daniel Korya
    Daniel Korya
    JFK Medical Center
    论文:11引用:0H-index:0
    Steven N. Kalkanis
    Steven N. Kalkanis
    Ford Health System Department of Neurosurgery, Henry
    论文:10引用:0H-index:0
    Michael Vogelbaum
    Michael Vogelbaum
    Moffitt Cancer Center;Research Institute, Inc
    论文:10引用:0H-index:0
    Joseph Landolfi
    Joseph Landolfi
    JFK Medical Center
    论文:10引用:0H-index:0
    Siddhart Mehta
    Siddhart Mehta
    JFK Medical Center
    论文:10引用:0H-index:0
    Larry M. Bush
    Larry M. Bush
    Miller Sch Med, Univ Miami
    论文:9引用:0H-index:0
    Maria T. Perez
    Maria T. Perez
    Integrated Regional Laboratory Pathology Services and Division of Pathology and Laboratory Medicine, JFK Medical Center
    论文:9引用:0H-index:0

    论文(205)

    年份
    起
    –
    止
    排序
    1E-137 Standalone Meningeal Artery Embolization in De Novo Vs Recurrent Chronic Subdural Hematomas: Multicenter Propensity-Score Matched Analysis
    M Salem,S Gomez-Paz, A Gajjar, A Helal,G Sioutas, O Kuybu, A Nguyen Hoang, J Davies,H Riina, B Howard,C Stapleton, C Griessenauer,
    2025SNIS 22nd annual meeting electronic poster abstracts(2025)
    引用
    AI阅读
    加入学术空间
    2E-040 Multicenter Registry Experience with the New Radial Catheter System Zebra
    V Srinivasan,B Jankowitz, B Yim,T White,J Catapano,J Burkhardt
    2025SNIS 22nd annual meeting electronic poster abstracts(2025)
    引用
    AI阅读
    加入学术空间
    3Eptifibatide Versus Standard of Care: A Retrospective Efficacy and Safety Analysis in Ischemic Stroke Patients Ineligible for Thrombolytics and Endovascular Therapy
    Shivankar Vajinepalli, Yong-Bum Song
    2025AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY(2025)
    引用
    AI阅读
    加入学术空间
    4HIV-1 Suppression and Rare Dolutegravir Resistance in Antiretroviral-Experienced People with HIV in Liberia
    James Soka Moses,Alice K Pau, Safia Kuriakose,Greg Grandits,Cavan Reilly,Brad T Sherman,Weizhong Chang, Lisheng Dai, Muhammad A Khan,Helene Highbarger, Moses Mannah, Johnathan McCullough,

    BACKGROUND:Increasingly, persons with HIV in Liberia are receiving antiretroviral therapy containing the integrase strand-transfer inhibitor (InSTI) dolutegravir (DTG), but the prevalence of and factors associated with virologic failure and HIV drug resistance (HIVDR) remain unknown. METHODS:Cross-sectional analysis of 2019-2022 enrolment data from 1276 persons with HIV in the HONOR cohort included sociodemographic information, plasma viral loads (pVL), CD4 counts, and HIVDR testing by next generation sequencing in participants with virologic failure (pVL≥1000 copies/mL). RESULTS:Of the 1201 participants with pVL results, 72% are female and median age is 42 (interquartile range [IQR] 35-50) years. All are on ART (median 6.1 [2.1-11] years): 74% on DTG-based and 23% on non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens. Ninety (7.5%) had virologic failure; 970 (81%) are suppressed (<40 copies/mL). Virologic failure is less prevalent with DTG- versus NNRTI-based regimens (5.3% vs. 14%, adjusted prevalence ratio [aPR]=0.3, 95% confidence interval [CI] 0.2-0.5) and is associated with age <50 years, CD4 count <200 cells/µL, and hemoglobin <11 g/dL. In 70 participants with virologic failure and successful sequencing, HIVDR prevalence is 81% for any ARV, 5.7% for InSTIs, 79% for NNRTIs, and 61% for nucleos(t)ide reverse transcriptase inhibitors (NRTIs). Intermediate-to-high resistance to ≥1 NRTI in current ART is less prevalent with DTG+2NRTIs than NNRTI+2NRTIs regimens (aPR = 0.5, 95%CI 0.3-0.8). CONCLUSIONS:Most participants in the cohort are virologically-suppressed. Among those with virologic failure, HIVDR prevalence is high to NRTIs and NNRTIs, but low to InSTIs. Ongoing evaluation is necessary to determine the durability of DTG-based ART.

    2025Communications medicine(2025)
    引用
    AI阅读
    加入学术空间
    5O-035 the Mirror Registry: Use of the Aurora Surgiscope for Minimally Invasive Evacuation of Intracranial Hemorrhage
    R Achey,A Kashkoush, M Davison, C Kellner,B Jankowitz, T Shigematsu,A Siddiqui,J Davies,M Chicoine,K Vakharia,R Crowley,J Osbun,
    2025SNIS 22nd annual meeting oral abstracts(2025)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 205 篇论文

    合作机构(100)

    迈阿密大学合作论文 19
    加利福尼亚大学圣地亚哥分校合作论文 11
    克利夫兰诊所合作论文 10
    俄亥俄州立大学合作论文 10
    加利福尼亚州立大学洛杉矶分校合作论文 9
    亨利·福特医院合作论文 8
    University of Miami Health System合作论文 8
    加州大学旧金山分校合作论文 7
    拉什大学合作论文 6
    华盛顿大学合作论文 5

    机构统计